|
Number |
project name |
Main construction content |
Approval number |
Approval category |
Completed environmental protection acceptance |
|---|---|---|---|---|---|
|
1 |
Daxing Production Base Project of Beijing Minhai Biotechnology Co., Ltd. |
It covers an area of 80889.6m2, and has an office R & D building, a cell-free H. influenzae type b combined vaccine production plant, a japonic chickenpox production plant, an animal room, a dangerous goods store, a canteen, an integrated sewage treatment station |
Beijing Central Audit [2007] No. 777 |
report |
Passed the acceptance in December 2011 and approved the document number Jinghuan inspection [2011] No.284 |
|
2 |
Minhai Biological Industrialization Project of "Human Diploid Cell Rabies Vaccine" |
Annual output of 5 million (one million copies) human diploid cell rabies vaccine freeze-dried powder injection |
Jingxing Environmental Review [2012] No. 0212 |
report |
Passed the acceptance in March 2016, and approved the document number Jingxing Huanyan [2016] No. 36 |
|
3 |
23-valent pneumococcal polysaccharide vaccine industrialization project |
Annual production of 10 million 23-valent pneumococcal polysaccharide vaccines |
Jingxing Environmental Review [2012] No. 0171 |
report |
Passed the acceptance in May 2016 and approved the document number Jingxing Huanyan [2016] No. 78 |
|
4 |
Construction of a pilot platform for biological vaccines |
Annual production of 100,000 three-component pertussis vaccines (100,000 people), 15-valent pneumococcal conjugate vaccine 400,000 (100,000 people), ACYW135 meningococcal conjugate vaccine 300,000 (100,000 people), 5 100,000 rotavirus vaccines (100,000 copies), human diploid cell rabies vaccine freeze-dried powder injections 500,000 pieces / year (100,000 copies) |
Jingxing Environmental Audit [2012] No. 0251 |
report |
Cancel construction |
|
5 |
Pre-filled vaccine workshop construction project |
Annual production of 36 million pre-filled vaccines |
Jingxing Environmental Review [2013] No. 2 |
report |
2016年3月已通过验收，审批文号京兴环验[2016]32号 |
|
6 |
New vaccines Beijing engineering laboratory innovation capacity building project |
Engineering laboratory with 4 platforms: protein-bound vaccine platform, multi-link multivalent vaccine platform, oral vaccine platform and vaccine quality evaluation platform |
Jingxing Environmental Review [2012] No. 0288 |
report |
Environmental protection acceptance is being commissioned |
|
7 |
Pre-filling filling workshop construction project |
36 million pre-filled filling workshops |
Jingxing Environmental Audit
[2014] No. 220
|
report |
Address change environmental assessment has been approved, Jingxing Environmental Review [2019] No. 17 |
|
8 |
Beijing Minhai Biological Technology Co., Ltd. R & D and production building construction project |
Sub-packaging workshop, finished product cold storage, pure water station, etc. The production workshop includes one 15 million dose / year rabies vaccine (lyophilized) and one 20 million dose / year sIPV vaccine (liquid) production line; |
Beijing Central Audit
[2016] No. 203
|
report |
The acceptance conditions have not been met |
|
9 |
Construction project of Minhai Biological New Vaccine International Industrial Base (Phase I) |
It covers a total area of 90013.218m2, newly built production workshops, R & D buildings, sub-packaging storage buildings, animal houses, sewage treatment stations and supporting ancillary facilities, hazardous waste and dangerous goods warehouses, canteens and comprehensive service buildings, etc., with a total construction area of 149320m2. Annual production of 25 million doses of pneumococcal conjugate vaccine; 20 million doses of adsorbed cell-free leukoderma + inactivated poliomyelitis + Haemophilus influenzae type b five-pump vaccine; Mabella varicella series vaccine: Mabira combined attenuated live 20 million doses of vaccine, 5 million doses of live attenuated varicella varicella combined vaccine and 10 million doses of lyophilized live attenuated varicella vaccine. |
Beijing Central Audit
[2019] No. 53
|
report |
/ |